SF
GILD icon

Symphony Financial’s Gilead Sciences GILD Stock Holding History

Symphony Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$446K Buy
3,533
+1,005
+40% +$132K 0.05% 210
2026
Q1 		$348K Sell
2,528
-1,085
-30% -$152K 0.05% 206
2025
Q4 		$445K Sell
3,613
-275
-7% -$33.4K 0.06% 181
2025
Q3 		$436K Buy
3,888
+114
+3% +$13K 0.05% 174
2025
Q2 		$440K Buy
+3,774
New +$402K 0.06% 165
2025
Q1 		– Sell
-4,619
Closed -$429K – 145
2024
Q4 		$429K Buy
4,619
+196
+4% +$17.6K 0.07% 148
2024
Q3 		$370K Sell
4,423
-491
-10% -$37.5K 0.06% 163
2024
Q2 		$338K Sell
4,914
-3,423
-41% -$228K 0.06% 156
2024
Q1 		$611K Buy
8,337
+1,580
+23% +$121K 0.14% 108
2023
Q4 		$581K Buy
6,757
+1,791
+36% +$139K 0.13% 123
2023
Q3 		$368K Buy
4,966
+179
+4% +$13.8K 0.09% 116
2023
Q2 		$364K Buy
4,787
+2,031
+74% +$162K 0.09% 140
2023
Q1 		$224K Buy
2,756
+258
+10% +$21.4K 0.06% 194
2022
Q4 		$214K Buy
+2,498
New +$198K 0.06% 186
2021
Q2 		– Sell
-2,776
Closed -$200K – 173
2021
Q1 		$200K Buy
+2,776
New +$179K 0.05% 191

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Symphony Financial's GILD Position: Q2 2026 in Review

Symphony Financial increased its Gilead Sciences (GILD) stake by 40% in Q2 2026, buying an estimated $132K and bringing the position to 3,533 shares worth $446K. The position accounts for 0.05% of the portfolio, ranked #210.

Symphony Financial first reported a position in GILD in Q1 2021 and has held it in 15 quarters since. The position peaked at $611K in Q1 2024. 1,926 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Symphony Financial held 3,533 shares of Gilead Sciences worth $446K as of Q2 2026.
  • Symphony Financial bought 1,005 Gilead Sciences shares in Q2 2026, an estimated $132K.
  • Gilead Sciences made up 0.05% of Symphony Financial's portfolio in Q2 2026, its #210 holding.
  • Symphony Financial first reported a position in Gilead Sciences in Q1 2021 and has held it in 15 quarters since.
  • Symphony Financial's Gilead Sciences position peaked at $611K in Q1 2024.
  • 1,926 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.